 HOUSTON, May 17, 2022 GLOBE NEWSWIRE -- Aravive, Inc. Nasdaq: ARAV, a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease today announced that Gail McIntyre, Ph.D, DABT, Chief Executive Officer will present at the H.C. Wainwright Annual Global Investment Conference being held at the Fontainebleau Miami Beach Hotel May 23-26, 2022. 